Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors Treated With Clopidogrel and Aspirin

作者: Young-Hoon Jeong , Udaya S. Tantry , In-Suk Kim , Jin-Sin Koh , Tae Jung Kwon

DOI: 10.1161/CIRCINTERVENTIONS.111.962555

关键词: Interquartile rangePlateletMedicineClopidogrelMyocardial infarctionP2Y12SurgeryInternal medicineCYP2C19CardiologyAspirinPharmacodynamics

摘要: Background—As compared with whites, East Asians more often carry the cytochrome P450 (CYP) 2C19 loss-of-function (LOF) allele CYP2C19*3 variant. The influence of CYP2C19 LOF alleles (*2 and *3) on clopidogrel response clinical outcomes in acute myocardial infarction (AMI) has not been reported. We sought to evaluate effect variants pharmacodynamics long-term prognosis these patients. Methods Results—Patients who survived an AMI (n=266) were enrolled a single-center registry. Predischarge platelet reactivity was assessed light transmittance aggregometry VerifyNow P2Y12 assay; CYP2C19*2, *3, *17 ABCB1 3435C>T determined. primary end point composite cardiovascular death, nonfatal MI, ischemic stroke. median exposure 21 months (interquartile range, 13–29). related or events. Carri...

参考文章(45)
Jung-Won Suh, Seung-Pyo Lee, Kyung-Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Young-Seok Cho, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Seung-Woon Rha, Jang-Ho Bae, Taek-Geun Kwon, Jang-Whan Bae, Myeong-Chan Cho, Hyo-Soo Kim, Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease Journal of the American College of Cardiology. ,vol. 57, pp. 280- 289 ,(2011) , 10.1016/J.JACC.2010.08.631
Duk-Woo Park, Sung-Cheol Yun, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Myeong-Ki Hong, Sang-Sig Cheong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park, Stent Thrombosis, Clinical Events, and Influence of Prolonged Clopidogrel Use After Placement of Drug-Eluting Stent JACC: Cardiovascular Interventions. ,vol. 1, pp. 494- 503 ,(2008) , 10.1016/J.JCIN.2008.06.011
Patrick Gladding, Laura Panattoni, Mark Webster, Leslie Cho, Stephen Ellis, Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial. Jacc-cardiovascular Interventions. ,vol. 3, pp. 995- 1000 ,(2010) , 10.1016/J.JCIN.2010.08.012
Gilles Montalescot, Georges Sideris, Catherine Meuleman, Claire Bal-dit-Sollier, Nicolas Lellouche, Ph Gabriel Steg, Michel Slama, Olivier Milleron, Jean-Philippe Collet, Patrick Henry, Farzin Beygui, Ludovic Drouet, ALBION Trial Investigators, A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. Journal of the American College of Cardiology. ,vol. 48, pp. 931- 938 ,(2006) , 10.1016/J.JACC.2006.04.090
Duk-Woo Park, Sung-Cheol Yun, Jong-Young Lee, Won-Jang Kim, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park, C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation Circulation. ,vol. 120, pp. 1987- 1995 ,(2009) , 10.1161/CIRCULATIONAHA.109.876763
Kang-Yin Chen, Seung-Woon Rha, Yong-Jian Li, Kanhaiya L Poddar, Zhe Jin, Yoshiyasu Minami, Lin Wang, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong, Young Keun Ahn, Taek Jong Hong, Young Jo Kim, Seung Ho Hur, In Whan Seong, Jei Keon Chae, Myeong Chan Cho, Jang Ho Bae, Dong Hoon Choi, Yang Soo Jang, In Ho Chae, Chong Jin Kim, Jung Han Yoon, Wook Sung Chung, Ki Bae Seung, Seung Jung Park, None, Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Circulation. ,vol. 119, pp. 3207- 3214 ,(2009) , 10.1161/CIRCULATIONAHA.108.822791
Spencer B. King, Sidney C. Smith, John W. Hirshfeld, Alice K. Jacobs, Douglass A. Morrison, David O. Williams, Sidney C. Smith, Ted E. Feldman, John W. Hirshfeld, Alice K. Jacobs, Morton J. Kern, Spencer B. King, Douglass A. Morrison, William W. O’Neill, Hartzell V. Schaff, Patrick L. Whitlow, David O. Williams, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick Nishimura, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy, , 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association task force on practice guidelines Circulation. ,vol. 117, pp. 261- 295 ,(2008) , 10.1161/CIRCULATIONAHA.107.188208
Jessica L. Mega, Tabassome Simon, Jean-Philippe Collet, Jeffrey L. Anderson, Elliott M. Antman, Kevin Bliden, Christopher P. Cannon, Nicolas Danchin, Betti Giusti, Paul Gurbel, Benjamin D. Horne, Jean-Sebastian Hulot, Adnan Kastrati, Gilles Montalescot, Franz-Josef Neumann, Lei Shen, Dirk Sibbing, P. Gabriel Steg, Dietmar Trenk, Stephen D. Wiviott, Marc S. Sabatine, Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. ,vol. 304, pp. 1821- 1830 ,(2010) , 10.1001/JAMA.2010.1543
Young-Guk Ko, Jung-Won Suh, Bo Hyun Kim, Chan Joo Lee, Jung-Sun Kim, Donghoon Choi, Myeong-Ki Hong, Myung-Ki Seo, Tae-Jin Youn, In-Ho Chae, Dong Joo Choi, Yangsoo Jang, Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention American Heart Journal. ,vol. 161, pp. 383- 390 ,(2011) , 10.1016/J.AHJ.2010.10.036